#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage IV Immune-mediated myositis Alexander disease Cervix carcinoma recurrent Ewing's sarcoma recurrent Small cell lung cancer extensive stage Acquired ATTR amyloidosis MELAS syndrome Hypersensitivity pneumonitis Precursor T-lymphoblastic lymphoma/leukaemia recurrent Glomerulonephritis rapidly progressive Candida infection Hepatic cirrhosis Uveal melanoma Immune-mediated renal disorder More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Trials in Disease Cystic fibrosis lung – Diagnostics Aicardi-Goutieres syndrome – Basic Information Waldenstrom’s macroglobulinaemia – Treatment Pemphigoid Sarcoma – Treatment Haemophilia B with anti factor IX – Life with Disease Congenital nephrogenic diabetes insipidus – Treatment Nephroblastoma Medulloblastoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nortriptyline Ivosidenib Cd7-Cart01 Oxygen Ph.eur. Dirocaftor Pyrazinamide Pemetrexed Disodium Alpelisib Metformin Hydrochloride Belantamab Mafodotin Quercus Robur Pollen Extract Dexibuprofen Vitamin A Bp Cobamamide Chloropyramine Hydrochloride Desonide Foscarnet AP31969 SULFATE Doxylamine Hydrogen Succinate Mebendazole More therapies…

    Learn about Your Condition

    Bipolar disorder Thrombosis Thromboangiitis obliterans Oropharyngeal cancer Stress cardiomyopathy Electronic cigarette user Colorectal adenoma Malignant lymphoid neoplasm Osteosarcoma Haemolytic uraemic syndrome Prostate cancer metastatic Skin papilloma Familial hypertriglyceridaemia Immune-mediated renal disorder Laryngeal cancer stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on Deferoxamine to Improve Hypoxia Response in Type 1 Diabetes Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypoxia
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Deferoxamine Mesilate
    Sweden
  • Study of Pioglitazone and Metformin combination treatment for patients with Metabolic Associated Fatty Liver Disease and prediabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Pioglitazone
    • Metformin Hydrochloride
    Spain
  • Study on the Effects of Intraperitoneal Furosemide in Patients with Heart Failure on Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Spain
  • Study Comparing Sodium Chloride and Sodium Lactate for Treating Severe Diabetic Ketoacidosis in ICU Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic ketoacidosis
    Investigated Drugs:
    • Sodium Lactate
    • Sodium Chloride
    France
  • Study on the Effectiveness and Safety of Orforglipron for Weight Management in Adolescents with Obesity or Overweight

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Italy Poland
  • Study on the Effects of Testosterone Gel on Physical Performance in Critically Ill Patients Requiring Long-Term Mechanical Ventilation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Testosterone
    • Placebo
    France
Previous Page
1 … 10 11 12 13 14 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!